Patient-Centered Measures of Treatment Benefit

Affiliations

¹ Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: Eric.Leifer@nih.gov.
² Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.

Free article

Editorial

Eric S Leifer et al. JACC Heart Fail. 2020 Dec.

Free article

. 2020 Dec;8(12):996-998.

doi: 10.1016/j.jchf.2020.09.003. Epub 2020 Oct 7.

¹ Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: Eric.Leifer@nih.gov.
² Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.

No abstract available

Keywords: clinical trials; heart failure; proportional hazards; trials.

Conflict of interest statement

Author Disclosures Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation.
Perego C, Sbolli M, Specchia C, Fiuzat M, McCaw ZR, Metra M, Oriecuia C, Peveri G, Wei LJ, O'Connor CM, Psotka MA. Perego C, et al. JACC Heart Fail. 2020 Dec;8(12):973-983. doi: 10.1016/j.jchf.2020.07.005. Epub 2020 Oct 7. JACC Heart Fail. 2020. PMID: 33039446
Estimating the Lifetime Benefits of Treatments for Heart Failure.
Ferreira JP, Docherty KF, Stienen S, Jhund PS, Claggett BL, Solomon SD, Petrie MC, Gregson J, Pocock SJ, Zannad F, McMurray JJV. Ferreira JP, et al. JACC Heart Fail. 2020 Dec;8(12):984-995. doi: 10.1016/j.jchf.2020.08.004. Epub 2020 Oct 7. JACC Heart Fail. 2020. PMID: 33039448 Free PMC article.